Kolaleh Eskandanian, PhD, MBA, PMP is executive director of the Sheikh Zayed Institute for Pediatric Surgical Innovation. She joined the Institute in May 2012 to assist Dr. Peter Kim in creating, implementing, and sustaining strategic initiatives for the Institute. Prior to joining academia, Dr. Eskandanian held a variety of management positions at Accenture, a $28 billion multinational management consulting company, where she was retained by top Fortune 500 companies to direct major product launches, strategy development, and management consulting. In that capacity, she assumed profit/loss responsibility for multi-million-dollar projects. Her work with global organizations built strong problem-solving skills and the ability to successfully implement strategy. It also challenged her to consider new, innovative ideas and to change the status quo.
At Georgetown University, she was the lead inventor of the first-ever web-based adverse event reporting system that was successfully commercialized. In 2008, Dr. Eskandanian joined Children’s National to work with Dr. Jill Joseph to develop strategy and apply for the $20 million Clinical and Translational Science Award. She was an instrumental force in attaining the prestigious grant, which funds ground-breaking research across disciplines at Children’s National. Dr. Eskandanian has applied her extensive experience in industry and academia in the Institute’s unique environment, playing a critical role in mapping the strategy for sustainable growth and transforming innovative ideas into transformational solutions for children.
Dr. Eskandanian holds BS/MS in Mechanical Engineering, PhD in Operations Management and an MBA. She is fluent in four languages.